The global implantable collamer lens market size was valued at USD 335 million in 2024 and is projected to surpass around USD 1,167.73 million by 2034, expanding at a CAGR of 13.3% from 2024 to 2034.
The implantable collamer lens market involves developing collamer lenses to treat ocular disorders. Collamer lenses are implanted in cases of myopia (nearsightedness) and astigmatism. An implantable collamer lens (ICL) is made of a combination of plastic and collagen that are more flexible, lighter, and natural. The surgery is performed to treat poor eyesight with refractive errors and for people who don’t meet the criteria for LASIK surgery.
The increasing incidences of ocular disorders and rising awareness about ICL surgery drive the market. The rising demand for ICL is mainly because it eliminates the use of glasses or contact lenses and remains intact within the eye for a long time. The demand for vision correction procedures like ICLs increases as they enhance the quality of life of patients due to lifestyle conveniences and aesthetics.
Technological advancements and suitable regulatory frameworks present promising future implantable collamer lens market growth opportunities. Advanced technologies can lead to customized designs and bioengineered materials enhancing customer satisfaction. Several government and private organizations provide funding and release guidelines for eliminating eye-related disorders, which promotes the use of ICL.
Published by Ajit Bansod
